Table 5.

Modified SLEDAI scores in relation to occurrence of individual ANA specificities in sera and IC.

	Serum				IC
ANA	SLEDAI median in antibody neg/pos patients Sudan	P	SLEDAI median in antibody neg/pos patients Sweden	P	SLEDAI median in antibody neg/pos patients Sudan	P	SLEDAI median in antibody neg/pos patients Sweden	P
SSA/Ro52	0/0	0.3	0/1	0.07	0/0	0.6	0/1	0.08
SSA/Ro60	0/0	0.2	0/1	0.007	0/0	0.5	0/1	0.02
SSB/La	0/1	0.2	0/0	0.2	0/0	0.9	0/0	0.6
Sm	0/3	0.0007	0/1	0.06	0/2	0.08	0/1	0.5
SmRNP	0/2	0.004	0/1	0.1	0/0	0.2	0/1	0.08
U1RNP	0/2	0.001	0/1	0.1	0/2	0.001	0/1	0.002
dsDNA	0/0	0.1	0/0	0.2	0/0	0.7	0/1	0.02
Histone	0/0	0.2	0/1	0.01	0/0	0.1	0/2	< 0.0001
Ribosomal P	0/2	0.3	0/1	0.1	0/0	0.3	0/0	0.9
PCNA	0/0	0.5	0/1	0.2	0/0	0.8	0/1	0.06

Data are expressed as median score of SLEDAI among autoantibody negative vs. positive patients. Significant P values are depicted in bold.